Skip to main content

UK Knee Osteoarthritis Treatment Arthrosamid For Pain & Stiffness Relief Launch

MSK Doctors (+4403300010048), a specialised network of private London, UK clinics, now offers patients battling knee osteoarthritis (OA) an advanced hydrogel injection called Arthrosamid, a treatment proven to outperform hyaluronic acid in reducing pain and stiffness and improving physical function.

-- This innovative, non-degradable, and non-resorbable hydrogel is composed of 2.5% cross-linked polyacrylamide and 97.5% non-pyrogenic water, offering a promising solution for long-lasting knee pain relief and improved joint function. Experts within the MSK Doctors network specialise in this new treatment for OA, giving patients access to the latest in intra-articular knee joint injections that can help stave off surgery.

More information is available at https://mskdoctors.com/treatments/arthrosamid

Arthrosamid works by adhering to the synovial membrane in the knee joint, acting as both a physical buffer and a scaffold for tissue regeneration. Clinical studies have demonstrated that Arthrosamid consistently outperforms traditional hyaluronic acid injections, showing numerically superior results in reducing pain, alleviating stiffness, and enhancing physical mobility. Patients report significant improvements lasting two to four years post-treatment, making it a groundbreaking solution for those struggling with chronic knee pain.

Because it is administered directly into the joint, the injection delivers powerful results. Its sound safety profile, as documented in numerous studies, reveals an absence of adverse effects, offering peace of mind to patients seeking effective, long-term pain relief.

“Arthrosamid has redefined how we manage knee osteoarthritis,” said Professor Paul Lee, Consultant Orthopaedic and Regenerative Surgeon and founder of MSK Doctors. “With a proven capacity to outperform hyaluronic acid in key areas like pain relief, stiffness reduction, and improved mobility, this hydrogel represents the next step forward in patient care, providing immediate relief and long-term improvements that can transform lives.”

For patients with moderate to severe osteoarthritis who have not found relief through other therapies, Arthrosamid is particularly beneficial. By reducing chronic pain and restoring joint function, Arthrosamid enables a broad range of patients - including professional athletes - to return to their daily lives, activities, and training schedules with renewed confidence and negligible discomfort.

By combining advanced treatments like Arthrosamid with a personalized approach to care, Professor Lee and his team are setting the standard in managing musculoskeletal conditions and enhancing patient quality of life.

About MSK Doctors

MSK Doctors remains at the forefront of musculoskeletal care, bringing innovative solutions like Arthrosamid to patients across the UK. Under the leadership of Professor Paul Lee, a pioneer in advanced MSK treatments and regenerative medicine, clinics within the network offer innovative and tailored interventions and therapies. Professor Lee’s expertise and dedication to integrating advanced technologies ensure patients have access to the innovative solutions they need.

Learn more by visiting https://mskdoctors.com.

Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com

Source: PressCable

Release ID: 89151592

In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.